Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase I
IMV Inc. to Present at Upcoming Investor Conference
Phase III
Kodiak Sciences to Host R&D Day on October 14 in San…
Phase I
Roche Vice Chairman Calls for Long-Term Thinking by Business to Save…
Approval
Marizyme Agrees to Distribute Somahlution’s DuraGraft Products in South America and…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
European Results From Global ETNA-AF Registry Show Low Bleeding and Low…
Deals
Some EpiPen and EpiPen Jr auto-injectors may be difficult to remove…
Commercial
AbbVie Stays Busy While Working to Complete Allergan Acquisition
Commercial
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim…
Home
Commercial
Lawsuits/Bankruptcy
Lawsuits/Bankruptcy
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Lawsuits/Bankruptcy
BioSpace Movers & Shakers, Oct. 11
Biospace News
-
October 11, 2019
Lawsuits/Bankruptcy
Novartis Close to Settling Kickback Lawsuit
Lawsuits/Bankruptcy
Reckitt Benckiser to pay $1.4 billion to settle US probes into Suboxone Film marketing practices
Lawsuits/Bankruptcy
States Pause Lawsuits Against Insys During Bankruptcy Proceedings
Lawsuits/Bankruptcy
TEVA PHARMACEUTICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead...
Lawsuits/Bankruptcy
Legal Battle Over Between ‘Pharma Bro’ Martin Shkreli and Retrophin
Biospace News
-
June 21, 2019
0
Lawsuits/Bankruptcy
Vectura Wins US GSK Patent Litigation and Awarded $89.7Million in Damages...
Biospace News
-
May 4, 2019
0
Lawsuits/Bankruptcy
Lawsuits Flow in Over Tainted Blood Pressure Drugs
Biospace News
-
April 25, 2019
0
Lawsuits/Bankruptcy
Government Files Criminal Charges Against Opioid Distributor and Two Former Executives
Biospace News
-
April 24, 2019
0
Lawsuits/Bankruptcy
Lannett Shares Fall After Article Raises Questions Regarding Anti-Trust Lawsuits and...
Biospace News
-
April 17, 2019
0
1
2
3
...
9
Page 1 of 9
- Advertisement -
MOST POPULAR
BioNTech to Acquire Antibody Generation Unit of MAB Discovery
January 23, 2019
Vect-Horus Announces Collaboration and Option Agreement with Astellas Pharma
June 4, 2019
Alexion and Dicerna Announce Collaboration to Discover and Develop RNAi Therapies...
October 26, 2018
BioPharmX Completes 1-for-25 Reverse Stock Split
April 26, 2019
Load more
HOT NEWS
Commercial
Vaccibody AS to present data on VB10.NEO and VB10.16 at upcoming...
Phase III
Provention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031 (Teplizumab)...
Others
ACC Preview: Apple Watch, Cardiac Device Trials, Keto Diet and More
Commercial
AFYX Therapeutics Presents Framework for Patient-Reported Oral Lichen Planus Symptom Severity...
